Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
Oncotarget|March 16, 2018
Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse modelsKei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Cancer Letters|October 23, 2019
Patient-derived orthotopic xenograft models of sarcomaKentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Frontiers in Oncology|October 10, 2022
Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE studyAkihiko Takeuchi, Makoto Endo, Akira Kawai, et al.
Journal of Cellular Biochemistry|June 23, 2018
Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcomaTasuku Kiyuna, Yasunori Tome, Takashi Murakami, et al.
Anticancer Research|October 3, 2018
Oral Recombinant Methioninase Combined with Caffeine and Doxorubicin Induced Regression of a Doxorubicin-resistant Synovial Sarcoma in a PDOX Mouse ModelTakashi Higuchi, Kei Kawaguchi, Kentaro Miyake, et al.
Cell Cycle (Georgetown, Tex.)|March 16, 2017
The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years agoTakashi Murakami, Tasuku Kiyuna, Kei Kawaguchi, et al.
Oncotarget|December 29, 2016
Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drugTakashi Murakami, Kentaro Igarashi, Kei Kawaguchi, et al.
Biochemical and Biophysical Research Communications|February 27, 2018
Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse modelsKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Journal of Cellular Biochemistry|May 9, 2018
Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapyKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
JCO Precision Oncology|January 8, 2019
Clinical Factors That Affect the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts: A University of California, Los Angeles, Sarcoma Program Prospective Clinical TrialTara A Russell, Mark A Eckardt, Takashi Murakami, et al.
Pageof 24